📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Verax Biomedical

1.1 - Company Overview

Verax Biomedical Logo

Verax Biomedical

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of rapid tests for detecting bacterial contamination in cellular components for transfusion or transplant, including FDA-cleared Platelet PGD and PGDprime tests (now detecting Acinetobacter) and 7 Day Platelet Dating with PGD enabling 7-day platelet dating to improve platelet safety and availability while reducing costs.

Products and services

  • 7 Day Platelet Dating with PGD: An FDA-cleared rapid test enabling 7-day platelet dating, improving platelet safety and availability while reducing costs
  • Platelet PGDprime Test: An updated assay rapid test for detecting bacterial contamination in platelets, now updated to detect Acinetobacter species
  • Platelet PGD Test: An FDA-cleared rapid test detecting bacterial contamination in platelets, serving as a safety measure for various types of platelets

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Verax Biomedical

NovaDigm Therapeutics Logo

NovaDigm Therapeutics

HQ: United States Website
  • Description: Provider of vaccines that protect patients from contracting fungal and bacterial infections.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NovaDigm Therapeutics company profile →
DelSiTech Logo

DelSiTech

HQ: Finland Website
  • Description: Provider of biodegradable silica-based controlled-release drug delivery technologies and drug development services, focusing on parenteral and local administration. Offers Silica Matrix platform for small molecules, biopharmaceuticals, and viral vectors; long-acting injectables, ocular drug delivery, and supergeneric/505(b)(2) products such as DST1308 and DST2105.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DelSiTech company profile →
Melinta Logo

Melinta

HQ: United States Website
  • Description: Provider of antibiotics, developing and commercializing antibiotics to overcome drug-resistant infections.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Melinta company profile →
Cubist Logo

Cubist

HQ: United States Website
  • Description: Provider of biopharmaceutical products focused on the research, development, and commercialization of therapies addressing unmet medical needs in the acute care environment; markets CUBICIN (daptomycin for injection), the first antibiotic in a new class of anti-infectives called lipopeptides.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cubist company profile →
LigoCyte Pharmaceuticals Logo

LigoCyte Pharmaceuticals

HQ: United States Website
  • Description: Provider of vaccines and monoclonal antibodies for gastrointestinal and respiratory indications, developing novel immunomodulatory drug compounds that modify immune responses by targeting cell binding interactions for the treatment of inflammatory and infectious diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full LigoCyte Pharmaceuticals company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Verax Biomedical

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Verax Biomedical

2.2 - Growth funds investing in similar companies to Verax Biomedical

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Verax Biomedical

4.2 - Public trading comparable groups for Verax Biomedical

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Verax Biomedical

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Verax Biomedical

What does Verax Biomedical do?

Verax Biomedical is a provider of rapid tests for detecting bacterial contamination in cellular components for transfusion or transplant, including FDA-cleared Platelet PGD and PGDprime tests (now detecting Acinetobacter) and 7 Day Platelet Dating with PGD enabling 7-day platelet dating to improve platelet safety and availability while reducing costs.

Who are Verax Biomedical's competitors?

Verax Biomedical's competitors and similar companies include NovaDigm Therapeutics, DelSiTech, Melinta, Cubist, and LigoCyte Pharmaceuticals.

Where is Verax Biomedical headquartered?

Verax Biomedical is headquartered in United States.

How many employees does Verax Biomedical have?

Verax Biomedical has 1,000 employees 🔒.

When was Verax Biomedical founded?

Verax Biomedical was founded in 2010 🔒.

What sector and industry vertical is Verax Biomedical in?

Verax Biomedical is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Verax Biomedical

Who are the top strategic acquirers in Verax Biomedical's sector and industry

Top strategic M&A buyers and acquirers in Verax Biomedical's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Verax Biomedical?

Top strategic M&A buyers groups and sectors for Verax Biomedical include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Verax Biomedical's sector and industry vertical

Which are the top PE firms investing in Verax Biomedical's sector and industry vertical?

Top PE firms investing in Verax Biomedical's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Verax Biomedical's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Verax Biomedical's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Verax Biomedical's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Verax Biomedical include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Verax Biomedical's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Verax Biomedical?

The key public trading comparables and valuation benchmarks for Verax Biomedical include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Verax Biomedical for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Verax Biomedical with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Verax Biomedical's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Verax Biomedical with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Verax Biomedical's' sector and industry vertical?

Access recent funding rounds and capital raises in Verax Biomedical's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Verax Biomedical